← Leaderboards
Christina C. Wang
La Biomed Res Inst/ Harbor Ucla Med Ctr
$7,924,844
Attributed
$7,924,844
Total exposure
43
Grants
28
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,924,844 · 43
By mechanism
M01$3,501,577 · 37
R25$2,168,534 · 1
R01$1,160,380 · 1
P50$529,908 · 2
S10$487,445 · 1
U13$77,000 · 1
Top collaborators
No co-investigators on record.
Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr
Same institution · by research overlap
- Ronald Sherwin Swerdloff$7,352,119
Others in their field
Top investigators on “Male”
- Myron E Essex · Harvard University (Sch Of Public Hlth)$47,217,905
- Kc Kent Lloyd · University Of California At Davis$33,183,422
- Linda A Teplin · Northwestern University$32,082,912
- Beth Baseler · Leidos Biomedical Research, Inc.$30,337,006
- Edie C Goldsmith · University Of South Carolina At Columbia$30,062,912
- Kevin A. Pelphrey · University Of California Los Angeles$29,809,496
Research focus
MaleClinical ResearchHuman SubjectInstitutionResearch PersonnelTestosteroneAndrogensUnited States National Institutes Of HealthFundingSourceResourcesGrantComputer Retrieval Of Information On Scientific Projects DatabaseHuman Therapy EvaluationHormonesClinical TrialsBloodUniversity StudentDosePharmaceutical PreparationsBaseSpermatogenesisSafetySpermatogenesis Inhibitor
Grant awards (79)
Community Outreach and Education Core (Core B)$115,082
P50 · FY2024 · HD · contact PI
Community Outreach and Education Core (Core B)$116,245
P50 · FY2023 · HD · contact PI
Community Outreach and Education Core (Core B)$116,114
P50 · FY2022 · HD · contact PI
Community Outreach and Education Core (Core B)$115,931
P50 · FY2020 · HD · contact PI
Community Outreach and Education Core (Core B)$66,536
P50 · FY2019 · HD · contact PI
GENERAL CLINICAL RESEARCH CENTER$1
M01 · FY2011 · RR · contact PI
A MULTICENTER, RANDOMIZED COMPARATOR TRIAL OF THE SAFETY AND SPERM AND GONADOTRO$197,203
M01 · FY2010 · RR · contact PI
HYPOPITUITARISM IN RETIRED PROFESSIONAL FOOTBALL PLAYERS$84,780
M01 · FY2010 · RR · contact PI
DEVELOPMENT AND VALIDATION OF STEROID AND OTHER ASSAYS BY LIQUID CHROMATOGRAPHY$78,007
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: TRIAL TO EVALUATE THE EFFECTIVENESS AND SAFETY OF DIFF DOSES OF$69,114
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: A MULTIPLE DOSE, PHARMACOKINETIC STUDY$18,431
M01 · FY2010 · RR · contact PI
C PATIENTS$12,902
M01 · FY2010 · RR · contact PI
AN OPEN-LABEL, MULTICENTER, PHASE II STUDY EVALUATING THE SAFETY AND EFFICACY O$1,844
M01 · FY2010 · RR · contact PI
Liquid Chromatography Tandem Mass Spectrometry$487,445
S10 · FY2009 · RR · contact PI
CLINICAL TRIAL: A MULTIPLE DOSE, PHARMACOKINETIC STUDY$328,555
M01 · FY2009 · RR · contact PI
A PHASE II, RANDOMISED, FOUR-WAY CROSSOVER STUDY TO COMPARE THE STEADY STATE$87,489
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: TRIAL TO EVALUATE THE EFFECTIVENESS AND SAFETY OF DIFF DOSES OF$80,975
M01 · FY2009 · RR · contact PI
DIETARY FAT AND INTRAPROSTATIC ANDROGENS: IMPLICATIONS FOR PROSTATE CANCER DE$30,715
M01 · FY2009 · RR · contact PI
American Society of Andrology Annual Meeting$17,500
U13 · FY2009 · HD · contact PI
AN OPEN-LABEL, MULTICENTER, PHASE II STUDY EVALUATING THE SAFETY AND EFFICACY O$11,169
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: A RANDOMIZED, OPEN LABEL CLINICAL TRIAL TO EVALUATE IF NESTORONE$67,249
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: A PHASE II RANDOMIZED, CROSS-OVER STUDY TO COMPARE THE STEADY ST$66,517
M01 · FY2008 · RR · contact PI
DIETARY FAT AND INTRAPROSTATIC ANDROGENS: IMPLICATIONS FOR PROSTATE CANCER DE$38,009
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: A PHASE II, RANDOMIZED, FOUR-WAY CROSSOVER STUDY TO COMPARE THE$24,852
M01 · FY2008 · RR · contact PI
American Society of Andrology Annual Meeting$20,500
U13 · FY2008 · HD · contact PI
CLINICAL TRIAL: AN OPEN-LABEL, MULTICENTER, PHASE II STUDY EVALUATING THE SAFETY$5,116
M01 · FY2008 · RR · contact PI
DOES NESTORONE GEL HAVE GONADOTROPIN SUPPRESSIVE ACTIVITY AND DEMONSTRATE AN$83,884
M01 · FY2007 · RR · contact PI
DIETARY FAT AND INTRAPROSTATIC ANDROGENS: IMPLICATIONS FOR PROSTATE CANCER DE$40,322
M01 · FY2007 · RR · contact PI
American Society of Andrology Annual Meeting$19,500
U13 · FY2007 · HD · contact PI
A PHASE II RANDOMIZED, CROSS-OVER STUDY TO COMPARE THE STEADY STATE PHARMACOK$7,202
M01 · FY2007 · RR · contact PI
DIETARY FAT AND INTRAPROSTATIC ANDROGENS: IMPLICATIONS FOR PROSTATE CANCER DE$115,936
M01 · FY2006 · RR · contact PI
A SINGLE-CENTER, OPEN-LABEL TRIAL TO COMPARE DIFFERENT ANALYTICAL ASSAYS FOR$111,574
M01 · FY2006 · RR · contact PI
American Society of Andrology Annual Meeting$19,500
U13 · FY2006 · HD · contact PI
DOES NESTORONE GEL HAVE GONADOTROPIN SUPPRESSIVE ACTIVITY AND DEMONSTRATE AN$3,117
M01 · FY2006 · RR · contact PI
PHARMACOKINETICS OF TESTOSTERONE UNDECANOATE INJECTIONS IN HEALTHY MEN$268,576
M01 · FY2005 · RR
Harbor-UCLA Initiative for Minority Student Development$244,610
R25 · FY2005 · GM
DIETARY FAT AND INTRAPROSTATIC ANDROGENS: IMPLICATIONS FOR PROSTATE CANCER DEVET$195,442
M01 · FY2005 · RR
A RANDOMIZED, MULTICENTER, OPEN-LABEL DOSE-FINDING STUDY ON THE EFFECT OF MEN$25,218
M01 · FY2005 · RR
STUDY OF PHTHALATES IN PREGNANT WOMEN AND CHILDREN$22,507
M01 · FY2005 · RR
PHTHALATE IN PREGNANT WOMEN AND CHILDREN$3,783
M01 · FY2005 · RR
Harbor-UCLA Initiative for Minority Student Development$316,059
R25 · FY2004 · GM
Prostate Cancer Development &Growth$296,345
R01 · FY2004 · DK
Dietary Fat and Intraprostatic Androgens: Implications for Prostate Cancer De...$236,212
M01 · FY2004 · RR
Randomized, Multicenter, Open-Label Dose-finding Study$211,179
M01 · FY2004 · RR
Pharmacokinetics of Testosterone Undecanoate Injections in Healthy Men$109,120
M01 · FY2004 · RR
Study of Phthalates in Pregnant Women and children$96,989
M01 · FY2004 · RR
Spermatogenesis Suppression with Norplant II&T Pellets vs Androgen Implants$34,662
M01 · FY2004 · RR
Phthalate in Pregnant Women and Children$16,046
M01 · FY2004 · RR
Harbor-UCLA Initiative for Minority Student Development$529,149
R25 · FY2003 · GM
Prostate Cancer Development &Growth$296,345
R01 · FY2003 · DK
Harbor-UCLA REI IMSD Equipment Supplement$142,908
R25 · FY2003 · GM
Harbor-UCLA Initiative for Minority Student Development$529,149
R25 · FY2002 · GM
Prostate Cancer Development &Growth$296,345
R01 · FY2002 · DK
Harbor-UCLA REI Initiative for CSUDH Minority Students$148,677
R25 · FY2002 · GM
Prostate Cancer Development &Growth$271,345
R01 · FY2001 · DK
DIETARY FAT MODULATION OF ANDROGEN (ESTROGEN) METABOLISM IN MEN$237,978
M01 · FY2001 · RR
PROGESTAGEN W/ TRANSDERMAL ANDROGEN VS TA ALONE TO SUPPRESS SPERMATOG$237,978
M01 · FY2001 · RR
EM574 ON SPERMATOGENESIS IN NORMAL MALE VOLUNTEERS$237,978
M01 · FY2001 · RR
INITIATIVE FOR MINORITY STUDENT DEVELOPMENT$35,308
R25 · FY2001 · GM
INITIATIVE FOR MINORITY STUDENT DEVELOPMENT$222,674
R25 · FY2000 · GM
DIETARY FAT MODULATION OF ANDROGEN (ESTROGEN) METABOLISM IN MEN$982
M01 · FY2000 · RR
PROGESTAGEN W/ TRANSDERMAL ANDROGEN VS TA ALONE TO SUPPRESS SPERMATOG$982
M01 · FY2000 · RR
EM574 ON SPERMATOGENESIS IN NORMAL MALE VOLUNTEERS$982
M01 · FY2000 · RR
Effect of testosterone on cognition in male patients with mild Alzheimer's diseas$0
M01 · FY2000 · RR
Efficacy of progesterone implant in comb with transdermal androgen vs transdermal$0
M01 · FY2000 · RR
Efficacy of progesterone implant in comb with transdermal androgen vs transdermal$0
M01 · FY2000 · RR
Efficacy of progesterone implant in comb with transdermal androgen vs transdermal$0
M01 · FY2000 · RR
Safety &effectiveness of testosterone-gel for hormonal replacement in hyppogonad$0
M01 · FY2000 · RR
Safety &effectiveness of testosterone-gel for hormonal replacement in hyppogonad$0
M01 · FY2000 · RR
Safety &effectiveness of testosterone-gel for hormonal replacement in hyppogonad$0
M01 · FY2000 · RR
US study of semen quality in partners of pregnant women$0
M01 · FY2000 · RR
US study of semen quality in partners of pregnant women$0
M01 · FY2000 · RR
US study of semen quality in partners of pregnant women$0
M01 · FY2000 · RR
PROGESTAGEN W/ TRANSDERMAL ANDROGEN VS TA ALONE TO SUPPRESS SPERMATOG$0
M01 · FY2000 · RR
PROGESTAGEN W/ TRANSDERMAL ANDROGEN VS TA ALONE TO SUPPRESS SPERMATOG$0
M01 · FY2000 · RR
DIETARY FAT MODULATION OF ANDROGEN (ESTROGEN) METABOLISM IN MEN$0
M01 · FY2000 · RR
DIETARY FAT MODULATION OF ANDROGEN (ESTROGEN) METABOLISM IN MEN$0
M01 · FY2000 · RR
Effect of testosterone on cognition in male patients with mild Alzheimer's diseas$0
M01 · FY2000 · RR
Effect of testosterone on cognition in male patients with mild Alzheimer's diseas$0
M01 · FY2000 · RR